TREA

87502726 - PLEXXIKON

Follow

Information

  • Trademark
  • 87502726
  • Serial Number
    87502726
  • Registration Number
    5390877
  • Filing Date
    June 23, 2017
    7 years ago
  • Registration Date
    January 30, 2018
    7 years ago
  • Transaction Date
    September 17, 2024
    7 months ago
  • Status Date
    August 09, 2024
    8 months ago
  • Published for Opposition Date
    November 14, 2017
    7 years ago
  • Location Date
    March 15, 2019
    6 years ago
  • First Use Anywhere Date
    December 22, 2003
    21 years ago
  • First Use In Commerce Date
    December 22, 2003
    21 years ago
  • Status Code
    710
  • Current Location
    POST REGISTRATION
    Employee Name
    HACK, ANDREA
  • Attorney Docket Number
    37JF-258127
    Attorney Name
    Harold Milstein
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
PLEXXIKON
Case File Statements
  • A00001: In the statement of goods, Class 42 Product development research, product development, and product development consultation regarding pharmaceutical, biological and biotechnological products; Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders is deleted and "Pharmaceutical product research, pharmaceutical product development, and pharmaceutical product research and development consultation regarding pharmaceutical products; medical research and development services for pharmaceuticals in the field of treatments for cancer, diabetes, autoimmune, bone, metabolic, and blood disorders; none of the above including diagnostic services or products or reagents" is inserted.
  • GS0051: Pharmaceutical preparations for the treatment of cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders
  • GS0421: * Pharmaceutical * product [ development ] research, * pharmaceutical * product development, and * pharmaceutical * product * research and * development consultation regarding pharmaceutical [, biological and biotechnological ] products; [ Pharmaceutical research and development services; ] medical research and development services * for pharmaceuticals * in the field of treatments for cancer, diabetes, [ and central nervous system, ] autoimmune, bone, metabolic, and blood disorders; * none of the above including diagnostic services or products or reagents *
Case File Event Statements
  • 9/22/2017 - 7 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/27/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/30/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/21/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/22/2017 - 7 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/22/2017 - 7 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/22/2017 - 7 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/22/2017 - 7 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/9/2017 - 7 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 10/25/2017 - 7 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/14/2017 - 7 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/14/2017 - 7 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/30/2018 - 7 years ago
    13 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/1/2018 - 6 years ago
    15 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/12/2018 - 7 years ago
    14 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 5/1/2018 - 6 years ago
    16 - AMENDMENT UNDER SECTION 7 - PROCESSED Type: A7OK
  • 3/7/2019 - 6 years ago
    17 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/7/2019 - 6 years ago
    18 - POST REGISTRATION ACTION CORRECTION Type: XXXX
  • 3/15/2019 - 6 years ago
    19 - AMENDMENT UNDER SECTION 7 - PROCESSED Type: A7OK
  • 4/15/2022 - 3 years ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/15/2022 - 3 years ago
    20 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/15/2022 - 3 years ago
    21 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/30/2023 - 2 years ago
    23 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 8/9/2024 - 8 months ago
    24 - CANCELLED SEC. 8 (6-YR) Type: C8..